- Home
- VATE vs NRXP Comparison
VATE vs NRXP Comparison
Compare VATE & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- NRXP
- Stock Information
- Founded
- VATE 1994
- NRXP 2015
- Country
- VATE United States
- NRXP United States
- Employees
- VATE N/A
- NRXP N/A
- Industry
- VATE Metal Fabrications
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- NRXP Health Care
- Exchange
- VATE Nasdaq
- NRXP Nasdaq
- Market Cap
- VATE 62.0M
- NRXP 58.5M
- IPO Year
- VATE 1996
- NRXP N/A
- Fundamental
- Price
- VATE $4.32
- NRXP $3.64
- Analyst Decision
- VATE
- NRXP Strong Buy
- Analyst Count
- VATE 0
- NRXP 5
- Target Price
- VATE N/A
- NRXP $31.40
- AVG Volume (30 Days)
- VATE 43.4K
- NRXP 421.9K
- Earning Date
- VATE 11-05-2025
- NRXP 11-13-2025
- Dividend Yield
- VATE N/A
- NRXP N/A
- EPS Growth
- VATE N/A
- NRXP N/A
- EPS
- VATE N/A
- NRXP N/A
- Revenue
- VATE $995,000,000.00
- NRXP N/A
- Revenue This Year
- VATE N/A
- NRXP N/A
- Revenue Next Year
- VATE N/A
- NRXP $395.09
- P/E Ratio
- VATE N/A
- NRXP N/A
- Revenue Growth
- VATE N/A
- NRXP N/A
- 52 Week Low
- VATE $3.35
- NRXP $1.10
- 52 Week High
- VATE $13.79
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- VATE 39.51
- NRXP 72.98
- Support Level
- VATE $4.53
- NRXP $3.19
- Resistance Level
- VATE $4.80
- NRXP $3.48
- Average True Range (ATR)
- VATE 0.33
- NRXP 0.21
- MACD
- VATE -0.04
- NRXP 0.05
- Stochastic Oscillator
- VATE 8.60
- NRXP 80.10
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.